CGS-12066 maleate
CGS-12066 maleate structure
|
Common Name | CGS-12066 maleate | ||
|---|---|---|---|---|
| CAS Number | 1350965-83-1 | Molecular Weight | 450.41 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C21H21F3N4O4 | Melting Point | N/A | |
| MSDS | USA | Flash Point | N/A | |
Use of CGS-12066 maleateCGS-12066 (maleate) is a 5-HT receptor agonist. CGS-12066 has agonist effect for 5-HT1A , 5-HT1B ,5-HT1C and 5-HT1D with pEC50 values of 6.41, 7.56, 4.05 and 7.11, respectively. CGS-12066 can be used for the research of neurological disease[1]. |
| Name | (E)-but-2-enedioic acid,4-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)pyrrolo[1,2-a]quinoxaline |
|---|---|
| Synonym | More Synonyms |
| Description | CGS-12066 (maleate) is a 5-HT receptor agonist. CGS-12066 has agonist effect for 5-HT1A , 5-HT1B ,5-HT1C and 5-HT1D with pEC50 values of 6.41, 7.56, 4.05 and 7.11, respectively. CGS-12066 can be used for the research of neurological disease[1]. |
|---|---|
| Related Catalog | |
| Target |
pEC50: 6.41 (5-HT1A), 7.56 (5-HT1B), 4.05 (5-HT1C) and 7.11 (5-HT1D)[1]. pKD: 7.19 (5-HT1A), 6.94 (5-HT1B), 4.89 (5-HT1C) and 7.49 (5-HT1D)[1]. |
| In Vitro | CGS-12066 (maleate) 对 5-HT1A、5-HT1B、5-HT1C 和 5-HT1D 具有激动作用，pEC50 值分别为 6.41、7.56、4.05 和 7.11[1]。 CGS-12066 (maleate) 对 5-HT1A、5-HT1B、5-HT1C和5-HT1D具有激动作用，pKD 值分别为 7.19、6.94、4.89 和 7.49[1]。 CGS-12066 (maleate) 以低效能刺激肌醇磷酸盐的积累[1]。 CGS-12066 (maleate) 作为部分激动剂抑制小腿黑质毛喉素刺激的腺苷酸环化酶活性[1]。 |
| References |
| Molecular Formula | C21H21F3N4O4 |
|---|---|
| Molecular Weight | 450.41 |
| Exact Mass | 450.15100 |
| PSA | 98.38000 |
| LogP | 2.97280 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
|
Functional consequence of the MET-T1010I polymorphism in breast cancer.
Oncotarget 6(5) , 2604-14, (2015) Major breast cancer predisposition genes, only account for approximately 30% of high-risk breast cancer families and only explain 15% of breast cancer familial relative risk. The HGF growth factor rec... |
|
|
Cell-cell adhesions and cell contractility are upregulated upon desmosome disruption.
PLoS ONE 9(7) , e101824, (2014) Desmosomes are perturbed in a number of disease states - including genetic disorders, autoimmune and bacterial diseases. Here, we report unexpected changes in other cell-cell adhesion structures upon ... |
|
|
MYC is a critical target of FBXW7.
Oncotarget 6(5) , 3292-305, (2015) MYC deregulation is a driver of many human cancers. Altering the balance of MYC protein levels at the level of transcription, protein stability, or turnover is sufficient to transform cells to a tumor... |
| 7-Trifluoromethyl-4-(4-methyl-1-piperazinyl)pyrrolo-[1,2-a]quinoxaline maleate salt |